Neopterin is a biomarker of the activation of cellular immunity. The purpose of this review is to summarise neopterin metabolism, methods of its detection, and its role in inflammation, focusing on periodontal inflammatory diseases. This derivative of guanosine is a non-enzymatic product of 7,8-dihydroneopterin oxidation caused by free radicals which protect activated macrophages from oxidative stress. Various methods, usually based on enzyme-linked immunosorbent essay, high-performance liquid chromatography, or radioimmunoassay were developed for the isolation of neopterin. A wide spectrum of diseases and conditions are known to affect neopterin levels, including cardiovascular, bacterial, viral, and degenerative diseases, as well as malignant tumours. Neopterin levels were found to increase in subjects with periodontitis, especially when the oral fluid and gingival crevicular fluid were evaluated. These findings confirm the role of activated macrophages and cellular immunity in periodontal inflammatory diseases. The gingival crevicular fluid and the oral fluid appear to be the most valuable biologic fluids for the evaluation of neopterin levels in periodontitis. For gingival crevicular fluid, neopterin can be determined as the concentration or the so-called total amount. Nonsurgical periodontal treatment was associated with a decrease in neopterin levels, but an increase was also reported, suggesting the possible role of macrophages in the resolution of the periodontal lesion.

Department of Dentistry Faculty of Medicine in Hradec Kralove Charles University Šimkova 870 500 03 Hradec Kralove Czech Republic

Department of Dentistry University Hospital Hradec Kralove Sokolská 581 500 05 Hradec Kralove Czech Republic

Zobrazit více v PubMed

Muller M.M., Curtius H.C., Herold M., Huber C.H. Neopterin in Clinical Practice. Clin. Chim. Acta. 1991;201:1–16. doi: 10.1016/0009-8981(91)90019-9. PubMed DOI

Fuchs D., Hausen A., Reibnegger G., Werner E.R., Dierich M.P., Wachter H. Neopterin as a Marker for Activated Cell-Mediated Immunity: Application in HIV Infection. Immunol. Today. 1988;9:150–155. doi: 10.1016/0167-5699(88)91203-0. PubMed DOI

Murr C., Widner B., Wirleitner B., Fuchs D. Neopterin as a Marker for Immune System Activation. Curr. Drug Metab. 2002;3:175–187. doi: 10.2174/1389200024605082. PubMed DOI

Rembold H., Buschmann L. Struktur und Synthese des Neopterins. Chem. Ber. 1963;96:1406–1410. doi: 10.1002/cber.19630960532. DOI

Hamerlinck F.F. Neopterin: A Review. Exp. Dermatol. 1999;8:167–176. doi: 10.1111/j.1600-0625.1999.tb00367.x. PubMed DOI

Rembold H., Buschmann L. Untersuchungen Über Die Pteridine Der Bienenpuppe (Apis Mellifica) Justus Liebigs Ann. Der Chem. 1963;662:72–82. doi: 10.1002/jlac.19636620108. DOI

Sakurai A., Goto M. Neopterin: Isolation from Human Urine. J. Biochem. 1967;61:142–145. doi: 10.1093/oxfordjournals.jbchem.a128513. PubMed DOI

Schneider-Crease I.A., Feder J.A., Baniel A., McCann C., Haile A.A., Abebe B., Fitzgerald L., Gomery M.A., Simberloff R.A., Petrie Z.L., et al. Urinary Neopterin Reflects Immunological Variation Associated with Age, Helminth Parasitism, and the Microbiome in a Wild Primate. Sci. Rep. 2022;12:21307. doi: 10.1038/s41598-022-25298-9. PubMed DOI PMC

Rasmi Y., Heidari N., Kübra Kırboğa K., Hatamkhani S., Tekin B., Alipour S., Naderi R., Farnamian Y., Akca I. The Importance of Neopterin in COVID-19: The Prognostic Value and Relation with the Disease Severity. Clin. Biochem. 2022;104:1–12. doi: 10.1016/j.clinbiochem.2022.03.002. PubMed DOI PMC

Heneberk O., Vernerova A., Kujovska Krcmova L., Wurfelova E., Radochova V. Neopterin Levels in Periodontitis and after Nonsurgical Periodontal Therapy: Evaluation of Gingival Crevicular Fluid, Oral Fluid, Serum and Urinary Samples—A Case-Control Study. Biomedicines. 2022;10:3200. doi: 10.3390/biomedicines10123200. PubMed DOI PMC

Pink R., Melichar B., Tomandl J., Blažková L., Tvrdý P., Zapletalová J. Salivary Neopterin Concentrations in Patients with Cancer of the Oral Cavity. Pteridines. 2016;27:53–58. doi: 10.1515/pterid-2015-0017. DOI

Dogheim G.M., Amralla M.T., Werida R.H. Role of Neopterin as an Inflammatory Biomarker in Congestive Heart Failure with Insights on Effect of Drug Therapies on Its Level. Inflammopharmacology. 2022;30:1617–1622. doi: 10.1007/s10787-022-01028-5. PubMed DOI PMC

Labouret M., Costi S., Bondet V., Trebossen V., Le Roux E., Ntorkou A., Bartoli S., Auvin S., Bader-Meunier B., Baudouin V., et al. Juvenile Neuropsychiatric Systemic Lupus Erythematosus: Identification of Novel Central Neuroinflammation Biomarkers. J. Clin. Immunol. 2022;43:615–624. doi: 10.1007/s10875-022-01407-1. PubMed DOI PMC

Huber C., Batchelor J.R., Fuchs D., Hausen A., Lang A., Niederwieser D., Reibnegger G., Swetly P., Troppmair J., Wachter H. Immune Response-Associated Production of Neopterin. Release from Macrophages Primarily under Control of Interferon-Gamma. J. Exp. Med. 1984;160:310–316. doi: 10.1084/jem.160.1.310. PubMed DOI PMC

Werner E.R., Werner-Felmayer G., Fuchs D., Hausen A., Reibnegger G., Yim J.J., Pfleiderer W., Wachter H. Tetrahydrobiopterin Biosynthetic Activities in Human Macrophages, Fibroblasts, THP-1, and T 24 Cells. GTP-Cyclohydrolase I Is Stimulated by Interferon-Gamma, and 6-Pyruvoyl Tetrahydropterin Synthase and Sepiapterin Reductase Are Constitutively Present. J. Biol. Chem. 1990;265:3189–3192. doi: 10.1016/S0021-9258(19)39752-2. PubMed DOI

Schoedon G., Troppmair J., Fontana A., Huber C., Curtius H.-C., Niederwieser A. Biosynthesis and Metabolism of Pterins in Peripheral Blood Mononuclear Cells and Leukemia Lines of Man and Mouse. Eur. J. Biochem. 1987;166:303–310. doi: 10.1111/j.1432-1033.1987.tb13515.x. PubMed DOI

Gieseg S.P., Baxter-Parker G., Lindsay A. Neopterin, Inflammation, and Oxidative Stress: What Could We Be Missing? Antioxidants. 2018;7:80. doi: 10.3390/antiox7070080. PubMed DOI PMC

Janmale T.V., Lindsay A., Gieseg S.P. Nucleoside Transporters Are Critical to the Uptake and Antioxidant Activity of 7,8-Dihydroneopterin in Monocytic Cells. Free Radic. Res. 2020;54:341–350. doi: 10.1080/10715762.2020.1764948. PubMed DOI

Werner-Felmayer G., Werner E.R., Fuchs D., Hausen A., Reibnegger G., Wachter H. Characteristics of Interferon Induced Tryptophan Metabolism in Human Cells in Vitro. Biochim. Biophys. Acta (BBA)-Mol. Cell Res. 1989;1012:140–147. doi: 10.1016/0167-4889(89)90087-6. PubMed DOI

Troppmair J., Nachbaur K., Herold M., Aulitzky W., Tilg H., Gastl G., Bieling P., Kotlan B., Flener R., Mull B., et al. In-Vitro and in-Vivo Studies on the Induction of Neopterin Biosynthesis by Cytokines, Alloantigens and Lipopolysaccharide (LPS) Clin. Exp. Immunol. 1988;74:392–397. PubMed PMC

Antoniades C., Cunnington C., Antonopoulos A., Neville M., Margaritis M., Demosthenous M., Bendall J., Hale A., Cerrato R., Tousoulis D., et al. Induction of Vascular GTP-Cyclohydrolase I and Endogenous Tetrahydrobiopterin Synthesis Protect Against Inflammation-Induced Endothelial Dysfunction in Human Atherosclerosis. Circulation. 2011;124:1860–1870. doi: 10.1161/CIRCULATIONAHA.111.029272. PubMed DOI PMC

Gieseg S.P., Reibnegger G., Wachter H., Esterbauer H. 7,8 Dihydroneopterin Inhibits Low Density Lipoprotein Oxidation in Vitro. Evidence That This Macrophage Secreted Pteridine Is an Anti-Oxidant. Free Radic. Res. 1995;23:123–136. doi: 10.3109/10715769509064027. PubMed DOI

Gieseg S.P., Crone E.M., Flavall E.A., Amit Z. Potential to Inhibit Growth of Atherosclerotic Plaque Development through Modulation of Macrophage Neopterin/7,8-Dihydroneopterin Synthesis: Effect of Neopterin/7,8-Dihydroneopterin. Br. J. Pharmacol. 2008;153:627–635. doi: 10.1038/sj.bjp.0707408. PubMed DOI PMC

Duggan S., Rait C., Platt A., Gieseg S.P. Protein and Thiol Oxidation in Cells Exposed to Peroxyl Radicals Is Inhibited by the Macrophage Synthesised Pterin 7,8-Dihydroneopterin. Biochim. Biophys. Acta (BBA)-Mol. Cell Res. 2002;1591:139–145. doi: 10.1016/S0167-4889(02)00272-0. PubMed DOI

Kojima S., Nomura T., Icho T., Kajiwara Y., Kitabatake K., Kubota K. Inhibitory Effect of Neopterin on NADPH-Dependent Superoxide-Generating Oxidase of Rat Peritoneal Macrophages. FEBS Lett. 1993;329:125–128. doi: 10.1016/0014-5793(93)80207-B. PubMed DOI

Gieseg S.P., Maghzal G., Glubb D. Protection of Erythrocytes by the Macrophage Synthesized Antioxidant 7,8 Dihydroneopterin. Free Radic. Res. 2001;34:123–136. doi: 10.1080/10715760100300121. PubMed DOI

Davies M.J. Protein Oxidation and Peroxidation. Biochem. J. 2016;473:805–825. doi: 10.1042/BJ20151227. PubMed DOI PMC

Yin H., Xu L., Porter N.A. Free Radical Lipid Peroxidation: Mechanisms and Analysis. Chem. Rev. 2011;111:5944–5972. doi: 10.1021/cr200084z. PubMed DOI

Zaloga G.P. Narrative Review of N-3 Polyunsaturated Fatty Acid Supplementation upon Immune Functions, Resolution Molecules and Lipid Peroxidation. Nutrients. 2021;13:662. doi: 10.3390/nu13020662. PubMed DOI PMC

Ayala A., Muñoz M.F., Argüelles S. Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal. Oxidative Med. Cell Longev. 2014;2014:1–31. doi: 10.1155/2014/360438. PubMed DOI PMC

Gieseg S.P., Pearson J., Firth C.A. Protein Hydroperoxides Are a Major Product of Low Density Lipoprotein Oxidation During Copper, Peroxyl Radical and Macrophage-Mediated Oxidation. Free Radic. Res. 2003;37:983–991. doi: 10.1080/10715760310001603612. PubMed DOI

Gieseg S.P., Cato S. Inhibition of THP-1 Cell-Mediated Low-Density Lipoprotein Oxidation by the Macrophage-Synthesised Pterin, 7,8-Dihydroneopterin. Redox Rep. 2003;8:113–115. doi: 10.1179/135100003125001396. PubMed DOI

Jebari-Benslaiman S., Galicia-García U., Larrea-Sebal A., Olaetxea J.R., Alloza I., Vandenbroeck K., Benito-Vicente A., Martín C. Pathophysiology of Atherosclerosis. Int. J. Mol. Sci. 2022;23:3346. doi: 10.3390/ijms23063346. PubMed DOI PMC

Parthasarathy S., Raghavamenon A., Garelnabi M.O., Santanam N. Oxidized Low-Density Lipoprotein. In: Uppu R.M., Murthy S.N., Pryor W.A., Parinandi N.L., editors. Free Radicals and Antioxidant Protocols. Volume 610. Humana Press; Totowa, NJ, USA: 2010. pp. 403–417. Methods in Molecular Biology. PubMed PMC

Baxter-Parker G., Prebble H.M., Cross S., Steyn N., Shchepetkina A., Hock B.D., Cousins A., Gieseg S.P. Neopterin Formation through Radical Scavenging of Superoxide by the Macrophage Synthesised Antioxidant 7,8-Dihydroneopterin. Free Radic. Biol. Med. 2020;152:142–151. doi: 10.1016/j.freeradbiomed.2020.03.002. PubMed DOI

Ghodsian N., Yeandle A., Hock B.D., Gieseg S.P. CD36 down Regulation by the Macrophage Antioxidant 7,8-Dihydroneopterin through Modulation of PPAR-γ Activity. Free Radic. Res. 2022;56:366–377. doi: 10.1080/10715762.2022.2114904. PubMed DOI

Gieseg S.P., Whybrow J., Glubb D., Rait C. Protection of U937 Cells from Free Radical Damage by the Macrophage Synthesized Antioxidant 7,8-Dihydroneopterin. Free Radic. Res. 2001;35:311–318. doi: 10.1080/10715760100300841. PubMed DOI

Denz H., Fuchs D., Huber H., Nachbaur D., Reibnegger G., Thaler J., Werner E.R., Wachter H. Correlation between Neopterin, Interferon-Gamma and Haemoglobin in Patients with Haematological Disorders. Eur. J. Haematol. 1990;44:186–189. doi: 10.1111/j.1600-0609.1990.tb00374.x. PubMed DOI

Werner E.R., Bichler A., Daxenbichler G., Fuchs D., Fuith L.C., Hausen A., Hetzel H., Reibnegger G., Wachter H. Determination of Neopterin in Serum and Urine. Clin. Chem. 1987;33:62–66. doi: 10.1093/clinchem/33.1.62. PubMed DOI

Berdowska A., Zwirska-Korczala K. Neopterin Measurement in Clinical Diagnosis. J. Clin. Pharm. Ther. 2001;26:319–329. doi: 10.1046/j.1365-2710.2001.00358.x. PubMed DOI

Jinkawa A., Shimizu M., Nishida K., Kaneko S., Usami M., Sakumura N., Irabu H., Takakuwa M., Inoue N., Mizuta M., et al. Cytokine Profile of Macrophage Activation Syndrome Associated with Kawasaki Disease. Cytokine. 2019;119:52–56. doi: 10.1016/j.cyto.2019.03.001. PubMed DOI

Wachter H., Fuchs D., Hausen A., Reibnegger G., Werner E.R. Advances in Clinical Chemistry. Volume 27. Elsevier; Amsterdam, The Netherlands: 1989. Neopterin as Marker for Activation of Cellular Immunity: Immunologic Basis and Clinical Application; pp. 81–141. PubMed

Widner B., Murr C., Wirleitner B., Mayr C., Spöttl N., Baier-Bitterlich G., Fuchs D. The Importance of Neopterin as a Laboratory Diagnostic Marker of Immune Activation. Pteridines. 1999;10:101–111. doi: 10.1515/pteridines.1999.10.3.101. DOI

Ozmeric N., Baydar T., Bodur A., Engin A.B., Uraz A., Eren K., Sahin G. Level of Neopterin, a Marker of Immune Cell Activation in Gingival Crevicular Fluid, Saliva, and Urine in Patients with Aggressive Periodontitis. J. Periodontol. 2002;73:720–725. doi: 10.1902/jop.2002.73.7.720. PubMed DOI

Plata-Nazar K., Jankowska A. Clinical Usefulness of Determining the Concentration of Neopterin. Pteridines. 2011;22:77–89. doi: 10.1515/pteridines.2011.22.1.77. DOI

Estelberge W., Weiss G., Petek W., Paletta B., Wächter H., Reibnegger G. Determination of Renal Clearance of Neopterin by a Pharmacokinetic Approach. FEBS Lett. 1993;329:13–16. doi: 10.1016/0014-5793(93)80182-T. PubMed DOI

Hagberg L., Dotevall L., Norkrans G., Larsson M., Wachter H., Fuchs D. Cerebrospinal Fluid Neopterin Concentrations in Central Nervous System Infection. J. Infect. Dis. 1993;168:1285–1288. doi: 10.1093/infdis/168.5.1285. PubMed DOI

Bogner J.R., Junge-Hülsing B., Kronawitter U., Sadri I., Matuschke A., Goebel F.-D. Expansion of Neopterin and Beta2-Microglobulin in Cerebrospinal Fluid Reaches Maximum Levels Early and Late in the Course of Human Immunodeficiency Virus Infection. Clin. Investig. 1992;70:665–669. doi: 10.1007/BF00180282. PubMed DOI

Dotevall L., Hagberg L., Fuchs D., Reibnegger G., Wachter H. Cerebrospinal Fluid and Serum Neopterin Levels in Patients with Lyme Neuroborreliosis. Infection. 1990;18:210–214. doi: 10.1007/BF01643387. PubMed DOI

Andersson L.M., Hagberg L., Fuchs D., Svennerholm B., Gisslen M. Increased Blood-Brain Barrier Permeability in Neuro-Asymptomatic HIV-1-Infected Individualscorrelation with Cerebrospinal Fluid HIV-1 RNA and Neopterin Levels. J. Neurovirol. 2001;7:542–547. doi: 10.1080/135502801753248123. PubMed DOI

Krcmova L.K., Cervinkova B., Solichova D., Sobotka L., Hansmanova L., Melichar B., Solich P. Fast and Sensitive HPLC Method for the Determination of Neopterin, Kynurenine and Tryptophan in Amniotic Fluid, Malignant Effusions and Wound Exudates. Bioanalysis. 2015;7:2751–2762. doi: 10.4155/bio.15.175. PubMed DOI

Vernerová A., Krčmová L.K., Heneberk O., Radochová V., Strouhal O., Kašparovský A., Melichar B., Švec F. Chromatographic Method for the Determination of Inflammatory Biomarkers and Uric Acid in Human Saliva. Talanta. 2021;233:122598. doi: 10.1016/j.talanta.2021.122598. PubMed DOI

Prasanna J.S., Sumadhura C. Biochemical Analysis of Three Biological Fluids and Its Response to Non-Surgical Periodontal Therapy in Pre and Postmenopausal Women with Periodontitis. J. Menopausal Med. 2019;25:149. doi: 10.6118/jmm.18179. PubMed DOI PMC

Vernerová A., Krčmová L.K., Heneberk O., Radochová V., Švec F. Liquid Chromatography Method with Tandem Mass Spectrometry and Fluorescence Detection for Determination of Inflammatory Biomarkers in Gingival Crevicular Fluid as a Tool for Diagnosis of Periodontal Disease. J. Pharm. Biomed. Anal. 2022;212:114644. doi: 10.1016/j.jpba.2022.114644. PubMed DOI

Solarino G., Bizzoca D., Moretti L., Vicenti G., Piazzolla A., Moretti B. What’s New in the Diagnosis of Periprosthetic Joint Infections: Focus on Synovial Fluid Biomarkers. Trop. Med. Infect. Dis. 2022;7:355. doi: 10.3390/tropicalmed7110355. PubMed DOI PMC

Melichar B., Solichova D., Freedman R.S. Neopterin as an Indicator of Immune Activation and Prognosis in Patients with Gynecological Malignancies. Int. J. Gynecol. Cancer. 2006;16:240–252. doi: 10.1111/j.1525-1438.2006.00294.x. PubMed DOI

Dhondt J.-L., Tilmont P., Ringel J., Farriaux J.-P. Pterins Analysis in Amniotic Fluid for the Prenatal Diagnosis of GTP Cyclohydrolase Deficiency. J. Inher. Metab. Dis. 1990;13:879–882. doi: 10.1007/BF01800213. PubMed DOI

Firth C.A., Laing A.D., Baird S.K., Pearson J., Gieseg S.P. Inflammatory Sites as a Source of Plasma Neopterin: Measurement of High Levels of Neopterin and Markers of Oxidative Stress in Pus Drained from Human Abscesses. Clin. Biochem. 2008;41:1078–1083. doi: 10.1016/j.clinbiochem.2008.06.008. PubMed DOI

Reibnegger G., Huber L.A., Jürgens G., Schönitzer D., Werner E.R., Wachter H., Wick G., Traill K.N. Approach to Define “Normal Aging” in Man. Immune Function, Serum Lipids, Lipoproteins and Neopterin Levels. Mech. Ageing Dev. 1988;46:67–82. doi: 10.1016/0047-6374(88)90115-7. PubMed DOI

Sack U., Burkhardt U., Borte M., Schädlich H., Berg K., Emmrich F. Age-Dependent Levels of Select Immunological Mediators in Sera of Healthy Children. Clin. Diagn. Lab. Immunol. 1998;5:28–32. doi: 10.1128/CDLI.5.1.28-32.1998. PubMed DOI PMC

Parrak V., Secnik P., Skrakova M. Neopterin Screening of Blood Donations. Pteridines. 2006;17:105–106. doi: 10.1515/pteridines.2006.17.4.105. DOI

Frick B., Schroecksnadel K., Neurauter G., Leblhuber F., Fuchs D. Increasing Production of Homocysteine and Neopterin and Degradation of Tryptophan with Older Age. Clin. Biochem. 2004;37:684–687. doi: 10.1016/j.clinbiochem.2004.02.007. PubMed DOI

Radunovic N., Kuczynski E., Rebarber A., Nastic D., Lockwood C.J. Neopterin Concentrations in Fetal and Maternal Blood: A Marker of Cell-Mediated Immune Activation. Am. J. Obstet. Gynecol. 1999;181:170–173. doi: 10.1016/S0002-9378(99)70455-2. PubMed DOI

Ikemoto K., Sumi-Ichinose C., Suganuma Y., Kano T., Ihira N., Nagatsu T., Kondo K. Salivary Neopterin and Related Pterins: Their Comparison to Those in Plasma and Changes in Individuals. J. Biochem. 2021;170:559–567. doi: 10.1093/jb/mvab076. PubMed DOI

Dántola M.L., Vignoni M., Capparelli A.L., Lorente C., Thomas A.H. Stability of 7,8-Dihydropterins in Air-Equilibrated Aqueous Solutions. Helv. Chim. Acta. 2008;91:411–425. doi: 10.1002/hlca.200890046. DOI

Flavall E.A., Crone E.M., Moore G.A., Gieseg S.P. Dissociation of Neopterin and 7,8-Dihydroneopterin from Plasma Components before HPLC Analysis. J. Chromatogr. B. 2008;863:167–171. doi: 10.1016/j.jchromb.2007.12.019. PubMed DOI

Jiménez Girón A., Martín-Tornero E., Hurtado Sánchez M.C., Durán Merás I., Espinosa Mansilla A. A Simple HPLC-ESI-MS Method for the Direct Determination of Ten Pteridinic Biomarkers in Human Urine. Talanta. 2012;101:465–472. doi: 10.1016/j.talanta.2012.09.061. PubMed DOI

Moutereau S., Ech Chad N., Devanlay M., Esmilaire L., Loric S. Improved Neopterin ELISA Kit: A Good Compromise between HPLC Results and Clinical Practice. Clin. Chem. Lab. Med. 2011;49:99–112. doi: 10.1515/CCLM.2011.071. PubMed DOI

Rokos H., Bienhaus G., Gadow A., Rokos K. Determination of neopterin and reduced neopterins by radioimmunoassay. In: Wachter H., Curtius H.C., Pfleiderer W., editors. February 23–March 2, 1985, St. Christoph, Arlberg, Austria. De Gruyter; Berlin, Germany: Boston, MA, USA: 1985. pp. 73–84.

Hammerer-Lercher A., Moser C., Leichtfried V., Schobersberger W., Griesmacher A., Fuchs D. Comparison of a Commercial Urinary Neopterin Radioimmunoassay with High Performance Liquid Chromatography. Clin. Chem. Lab. Med. 2012;50:1075–1078. doi: 10.1515/cclm-2011-0861. PubMed DOI

Makoto S., Tokio Y., Takashi S., Sadao M., Toshiharu N. Polarization Fluoroimmunoassay of Biopterin and Neopterin in Human Urine. Clin. Chim. Acta. 1984;138:275–282. doi: 10.1016/0009-8981(84)90134-7. PubMed DOI

Vrecko K., Staedtler P., Mischak I., Maresch L., Reibnegger G. Periodontitis and Concentrations of the Cellular Immune Activation Marker Neopterin in Saliva and Urine. Clin. Chim. Acta. 1997;268:31–40. doi: 10.1016/S0009-8981(97)00154-X. PubMed DOI

Bodur A., Baydar T., Ozmeric N., Engin A., Uraz A., Eren K., Sahin G. Neopterin Profile to Evaluate the Effectiveness of Treatment in Aggressive Periodontitis. Pteridines. 2003;14:77–81. doi: 10.1515/pteridines.2003.14.3.77. DOI

Prasanna J.S., Sumadhura C., Karunakar P., Rohini N. Comparative Evaluation of Salivary Neopterin Levels and Its Effects to Periodontal Therapy in Pre- and Post-Menopausal Women. J. Menopausal Med. 2017;23:32–41. doi: 10.6118/jmm.2017.23.1.32. PubMed DOI PMC

Mahendra L., Mahendra J., Borra S.K., Nagarajan A. Estimation of Salivary Neopterin in Chronic Periodontitis. Indian J. Dent. Res. 2014;25:794–796. doi: 10.4103/0970-9290.152207. PubMed DOI

Adachi T., Naruko T., Itoh A., Komatsu R., Abe Y., Shirai N., Yamashita H., Ehara S., Nakagawa M., Kitabayashi C., et al. Neopterin Is Associated with Plaque Inflammation and Destabilisation in Human Coronary Atherosclerotic Lesions. Heart. 2006;93:1537–1541. doi: 10.1136/hrt.2006.109736. PubMed DOI PMC

Zembron-Lacny A., Dziubek W., Tylutka A., Wacka E., Morawin B., Bulinska K., Stefanska M., Wozniewski M., Szuba A. Assessment of Serum Neopterin as a Biomarker in Peripheral Artery Disease. Diagnostics. 2021;11:1911. doi: 10.3390/diagnostics11101911. PubMed DOI PMC

Signorelli S.S., Anzaldi M., Fiore V., Candido S., Di Marco R., Mangano K., Quattrocchi C., Neri S. Neopterin: A Potential Marker in Chronic Peripheral Arterial Disease. Mol. Med. Rep. 2013;7:1855–1858. doi: 10.3892/mmr.2013.1407. PubMed DOI

McDermott M.M., Guralnik J.M., Corsi A., Albay M., Macchi C., Bandinelli S., Ferrucci L. Patterns of Inflammation Associated with Peripheral Arterial Disease: The InCHIANTI Study. Am. Heart J. 2005;150:276–281. doi: 10.1016/j.ahj.2004.09.032. PubMed DOI

Sugioka K., Naruko T., Hozumi T., Nakagawa M., Kitabayashi C., Ikura Y., Shirai N., Matsumura Y., Ehara S., Ujino K., et al. Elevated Levels of Neopterin Are Associated with Carotid Plaques with Complex Morphology in Patients with Stable Angina Pectoris. Atherosclerosis. 2010;208:524–530. doi: 10.1016/j.atherosclerosis.2009.07.054. PubMed DOI

Avanzas P. Markers of Inflammation and Multiple Complex Stenoses (Pancoronary Plaque Vulnerability) in Patients with Non-ST Segment Elevation Acute Coronary Syndromes. Heart. 2004;90:847–852. doi: 10.1136/hrt.2003.015826. PubMed DOI PMC

Ren J., Chen Y.-B., Zhang Y.-Y., Zhou Q.-B., Chen S., Yang J.-Y., Tao J. Decreased Circulating Neopterin Is Associated with Increased Arterial Elasticity: A Beneficial Role of Periodontal Treatment. Aust. Dent. J. 2016;61:76–83. doi: 10.1111/adj.12303. PubMed DOI

Parenica J., Kala P., Mebazaa A., Littnerova S., Benesova K., Tomandl J., Goldbergová Pavkova M., Jarkovský J., Spinar J., Tomandlova M., et al. Activation of the Nitric Oxide Pathway and Acute Myocardial Infarction Complicated by Acute Kidney Injury. Cardiorenal Med. 2020;10:85–96. doi: 10.1159/000503718. PubMed DOI

Grammer T.B., Fuchs D., Boehm B.O., Winkelmann B.R., Maerz W. Neopterin as a Predictor of Total and Cardiovascular Mortality in Individuals Undergoing Angiography in the Ludwigshafen Risk and Cardiovascular Health Study. Clin. Chem. 2009;55:1135–1146. doi: 10.1373/clinchem.2008.118844. PubMed DOI

Nechita V.-I., Hajjar N.A., Drugan C., Cătană C.-S., Moiş E., Nechita M.-A., Graur F. Chitotriosidase and Neopterin as Potential Biomarkers for the Evaluation of Complicated Cholecystitis—A Pilot Study. JCM. 2023;12:1641. doi: 10.3390/jcm12041641. PubMed DOI PMC

Kamal Z.B., Naji R.E., Ali H.A. Comparative Study between Neopterin and Alvarado Score in the Diagnosis of Acute Appendicitis and Its Severity. Maced. J. Med. Sci. 2021;9:42–47. doi: 10.3889/oamjms.2021.5465. DOI

Saghazadeh A., Rezaei N. Elevated Neopterin in Tuberculosis and Co-Infection with HIV and the Effect of Treatment: A Systematic Review, Meta-Analysis, and Meta-Regression. Int. Immunopharmacol. 2022;111:109147. doi: 10.1016/j.intimp.2022.109147. PubMed DOI

Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., Bloom B.R. An Essential Role for Interferon Gamma in Resistance to Mycobacterium Tuberculosis Infection. J. Exp. Med. 1993;178:2249–2254. doi: 10.1084/jem.178.6.2249. PubMed DOI PMC

Kaneko S., Hatasaki K., Ueno K., Fujita S., Igarashi N., Kuroda M., Wada T. One-Year-Old Boy with Refractory Listeria Monocytogenes Meningitis Due to Persistent Hypercytokinemia. J. Infect. Chemother. 2022;28:1682–1686. doi: 10.1016/j.jiac.2022.08.027. PubMed DOI

Kip A.E., Wasunna M., Alves F., Schellens J.H.M., Beijnen J.H., Musa A.M., Khalil E.A.G., Dorlo T.P.C. Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral Leishmaniasis. Front. Cell Infect. Microbiol. 2018;8:181. doi: 10.3389/fcimb.2018.00181. PubMed DOI PMC

Wirleitner B., Rudzite V., Neurauter G., Murr C., Kalnins U., Erglis A., Trusinskis K., Fuchs D. Immune Activation and Degradation of Tryptophan in Coronary Heart Disease. Eur. J. Clin. Investig. 2003;33:550–554. doi: 10.1046/j.1365-2362.2003.01186.x. PubMed DOI

Mildvan D., Spritzler J., Grossberg S.E., Fahey J.L., Johnston D.M., Schock B.R., Kagan J. Serum Neopterin, an Immune Activation Marker, Independently Predicts Disease Progression in Advanced HIV-1 Infection. Clin. Infect. Dis. 2005;40:853–858. doi: 10.1086/427877. PubMed DOI

Williams M.E., Stein D.J., Joska J.A., Naudé P.J.W. Cerebrospinal Fluid Immune Markers and HIV-Associated Neurocognitive Impairments: A Systematic Review. J. Neuroimmunol. 2021;358:577649. doi: 10.1016/j.jneuroim.2021.577649. PubMed DOI

Ozger H.S., Dizbay M., Corbacioglu S.K., Aysert P., Demirbas Z., Tunccan O.G., Hizel K., Bozdayi G., Caglar K. The Prognostic Role of Neopterin in COVID-19 Patients. J. Med. Virol. 2021;93:1520–1525. doi: 10.1002/jmv.26472. PubMed DOI

Robertson J., Gostner J.M., Nilsson S., Andersson L.-M., Fuchs D., Gisslen M. Serum Neopterin Levels in Relation to Mild and Severe COVID-19. BMC Infect. Dis. 2020;20:942. doi: 10.1186/s12879-020-05671-7. PubMed DOI PMC

Zheng B., Cao K.-Y., Chan C.P.Y., Choi J.W.Y., Leung W., Leung M., Duan Z.-H., Gao Y., Wang M., Di B., et al. Serum Neopterin for Early Assessment of Severity of Severe Acute Respiratory Syndrome. Clin. Immunol. 2005;116:18–26. doi: 10.1016/j.clim.2005.03.009. PubMed DOI PMC

Gulcan E.M., Tirit I., Anil A., Adal E., Ozbay G. Serum Neopterin Levels in Children with Hepatitis-B-Related Chronic Liver Disease and Its Relationship to Disease Severity. WJG. 2008;14:6840. doi: 10.3748/wjg.14.6840. PubMed DOI PMC

Leonardi S., Avola E., Sciacca A., Gregorio F.D., Musumeci S. Neopterin as a Marker of C Hepatitis in Thalassaemia Major. J. Pediatr. Gastroenterol. Nutr. 1991;12:315–318. doi: 10.1097/00005176-199104000-00004. PubMed DOI

Reibnegger G., Auhuber I., Fuchs D., Hausen A., Judmaier G., Prior C., Werner E.R., Wachter H. Urinary Neopterin Levels in Acute Viral Hepatitis. Hepatology. 1988;8:771–774. doi: 10.1002/hep.1840080412. PubMed DOI

Miyaue N., Hosokawa Y., Yamanishi Y., Tada S., Ando R., Nagai M. Clinical Use of CSF Neopterin Levels in CNS Demyelinating Diseases. J. Neurol. Sci. 2022;441:120385. doi: 10.1016/j.jns.2022.120385. PubMed DOI

Widner B., Leblhuber F., Fuchs D. Increased Neopterin Production and Tryptophan Degradation in Advanced Parkinson’s Disease. J. Neural Transm. 2002;109:181–189. doi: 10.1007/s007020200014. PubMed DOI

Arteaga-Henríquez G., Lugo-Marín J., Gisbert L., Setién-Ramos I., Martínez-Gallo M., Pujol-Borrell R., Ramos-Quiroga J.A. Activation of the Monocyte/Macrophage System and Abnormal Blood Levels of Lymphocyte Subpopulations in Individuals with Autism Spectrum Disorder: A Systematic Review and Meta-Analysis. Int. J. Mol. Sci. 2022;23:14329. doi: 10.3390/ijms232214329. PubMed DOI PMC

Endres D., Frye B.C., Schlump A., Kuzior H., Feige B., Nickel K., Urbach H., Schiele M.A., Domschke K., Berger B., et al. Sarcoidosis and Obsessive-Compulsive Symptoms. J. Neuroimmunol. 2022;373:577989. doi: 10.1016/j.jneuroim.2022.577989. PubMed DOI

Bahrehmand F., Vaisi-Raygani A., Kiani A., Rahimi Z., Tavilani H., Ardalan M., Vaisi-Raygani H., Shakiba E., Pourmotabbed T. Matrix Metalloproteinase 9 Polymorphisms and Systemic Lupus Erythematosus: Correlation with Systemic Inflammatory Markers and Oxidative Stress. Lupus. 2015;24:597–605. doi: 10.1177/0961203314559085. PubMed DOI

Abdel-Haq A., Kusnierz-Cabala B., Darczuk D., Sobuta E., Dumnicka P., Wojas-Pelc A., Chomyszyn-Gajewska M. Interleukin-6 and Neopterin Levels in the Serum and Saliva of Patients with Lichen Planus and Oral Lichen Planus. J. Oral Pathol. Med. 2014;43:734–739. doi: 10.1111/jop.12199. PubMed DOI

Peng Q.-L., Zhang Y.-M., Liang L., Liu X., Ye L.-F., Yang H.-B., Zhang L., Shu X.-M., Lu X., Wang G.-C. A High Level of Serum Neopterin Is Associated with Rapidly Progressive Interstitial Lung Disease and Reduced Survival in Dermatomyositis. Clin. Exp. Immunol. 2020;199:314–325. doi: 10.1111/cei.13404. PubMed DOI PMC

El-Lebedy D., Hussein J., Ashmawy I., Mohammed A.M. Serum Level of Neopterin Is Not a Marker of Disease Activity in Treated Rheumatoid Arthritis Patients. Clin. Rheumatol. 2017;36:1975–1979. doi: 10.1007/s10067-016-3433-4. PubMed DOI

Videm V., Houge I.S., Liff M.H., Hoff M. Inflammation Mediates Approximately One Quarter of Excess Relative All-Cause Mortality in Persons with Rheumatoid Arthritis: The Trøndelag Health Study. Sci. Rep. 2022;12:18599. doi: 10.1038/s41598-022-21977-9. PubMed DOI PMC

Hanahan D., Weinberg R.A. Hallmarks of Cancer: The Next Generation. Cell. 2011;144:646–674. doi: 10.1016/j.cell.2011.02.013. PubMed DOI

Melichar B., Spisarová M., Bartoušková M., Krčmová L.K., Javorská L., Študentová H. Neopterin as a Biomarker of Immune Response in Cancer Patients. Ann. Transl. Med. 2017;5:280. doi: 10.21037/atm.2017.06.29. PubMed DOI PMC

Ciocan A., Ciocan R.A., Al Hajjar N., Benea A.M., Pandrea S.L., Cătană C.S., Drugan C., Oprea V.C., Dîrzu D.S., Bolboacă S.D. Exploratory Evaluation of Neopterin and Chitotriosidase as Potential Circulating Biomarkers for Colorectal Cancer. Biomedicines. 2023;11:894. doi: 10.3390/biomedicines11030894. PubMed DOI PMC

Berchtold J., Murr C., Norer B., Waldhart E., Wachter H., Fuchs D. Urinary Neopterin Excretion in Patients with Squamous Carcinoma of the Oral Cavity. Cancer Lett. 1995;95:227–232. doi: 10.1016/0304-3835(95)03888-4. PubMed DOI

Murr C., Berchtold J., Norer B., Waldhart E., Wachter H., Fuchs D. Neopterin as a Prognostic Parameter in Patients with Squamous-Cell Carcinomas of the Oral Cavity. Int. J. Cancer. 1998;79:476–480. doi: 10.1002/(SICI)1097-0215(19981023)79:5<476::AID-IJC5>3.0.CO;2-Y. PubMed DOI

Weinlich G., Murr C., Richardsen L., Winkler C., Fuchs D. Decreased Serum Tryptophan Concentration Predicts Poor Prognosis in Malignant Melanoma Patients. Dermatology. 2007;214:8–14. doi: 10.1159/000096906. PubMed DOI

Hausen A., Fuchs D., Grünewald K., Huber H., König K., Wechter H. Urinary Neopterine as Marker for Haematological Neoplasias. Clin. Chim. Acta. 1981;117:297–305. doi: 10.1016/0009-8981(81)90117-0. PubMed DOI

Aulitzky W., Frick J., Fuchs D., Hausen A., Reibnegger G., Wachter H. Significance of Urinary Neopterin in Patients with Malignant Tumors of the Genitourinary Tract. Cancer. 1985;55:1052–1055. doi: 10.1002/1097-0142(19850301)55:5<1052::AID-CNCR2820550521>3.0.CO;2-9. PubMed DOI

Manes G., Spada O.A., Rabitti P.G., Feola B., Misso S., Minerva A., Uomo G. Neopterin Serum Levels in Pancreatic Adenocarcinoma. IJGC. 1999;25:31–38. doi: 10.1385/IJGC:25:1:31. PubMed DOI

Zuo H., Tell G.S., Vollset S.E., Ueland P.M., Nygård O., Midttun Ø., Meyer K., Ulvik A., Eussen S.J.P.M. Interferon-γ-Induced Inflammatory Markers and the Risk of Cancer: The Hordaland Health Study. Cancer. 2014;120:3370–3377. doi: 10.1002/cncr.28869. PubMed DOI PMC

Bizjak D.A., Schulz S.V.W., John L., Schellenberg J., Bizjak R., Witzel J., Valder S., Kostov T., Schalla J., Steinacker J.M., et al. Running for Your Life: Metabolic Effects of a 160.9/230 Km Non-Stop Ultramarathon Race on Body Composition, Inflammation, Heart Function, and Nutritional Parameters. Metabolites. 2022;12:1138. doi: 10.3390/metabo12111138. PubMed DOI PMC

Dantas de Lucas R., Caputo F., Mendes de Souza K., Sigwalt A.R., Ghisoni K., Lock Silveira P.C., Remor A.P., da Luz Scheffer D., Antonacci Guglielmo L.G., Latini A. Increased Platelet Oxidative Metabolism, Blood Oxidative Stress and Neopterin Levels after Ultra-Endurance Exercise. J. Sport. Sci. 2014;32:22–30. doi: 10.1080/02640414.2013.797098. PubMed DOI

Papapanou P.N., Sanz M., Buduneli N., Dietrich T., Feres M., Fine D.H., Flemmig T.F., Garcia R., Giannobile W.V., Graziani F., et al. Periodontitis: Consensus Report of Workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions: Classification and Case Definitions for Periodontitis. J. Clin. Periodontol. 2018;45:S162–S170. doi: 10.1111/jcpe.12946. PubMed DOI

Newman M.G., Takei H.H., Klokkevold P.R., Carranza F.A., editors. Carranza’s Clinical Periodontology. 20th ed. Elsevier Saunders; St. Louis, MO, USA: 2015.

Meyle J., Chapple I. Molecular Aspects of the Pathogenesis of Periodontitis. Periodontology 2000. 2015;69:7–17. doi: 10.1111/prd.12104. PubMed DOI

Grossi S.G., Zambon J.J., Ho A.W., Koch G., Dunford R.G., Machtei E.E., Norderyd O.M., Genco R.J. Assessment of Risk for Periodontal Disease. I. Risk Indicators for Attachment Loss. J. Periodontol. 1994;65:260–267. doi: 10.1902/jop.1994.65.3.260. PubMed DOI

Slots J. Periodontitis: Facts, Fallacies and the Future. Periodontology 2000. 2017;75:7–23. doi: 10.1111/prd.12221. PubMed DOI

Arango Duque G., Descoteaux A. Macrophage Cytokines: Involvement in Immunity and Infectious Diseases. Front. Immunol. 2014;5:491. doi: 10.3389/fimmu.2014.00491. PubMed DOI PMC

Yang J., Zhu Y., Duan D., Wang P., Xin Y., Bai L., Liu Y., Xu Y. Enhanced Activity of Macrophage M1/M2 Phenotypes in Periodontitis. Arch. Oral Biol. 2018;96:234–242. doi: 10.1016/j.archoralbio.2017.03.006. PubMed DOI

Mosser D.M., Edwards J.P. Exploring the Full Spectrum of Macrophage Activation. Nat. Rev. Immunol. 2008;8:958–969. doi: 10.1038/nri2448. PubMed DOI PMC

Zhou L., Bi C., Gao L., An Y., Chen F., Chen F. Macrophage Polarization in Human Gingival Tissue in Response to Periodontal Disease. Oral Dis. 2019;25:265–273. doi: 10.1111/odi.12983. PubMed DOI

Arjunkumar R., Sudhakar U., Jayakumar P., Arunachalam L., Suresh S., Virupapuram P. Comparative Analysis of Gingival Crevicular Fluid Neopterin Levels in Health and Periodontal Disease: A Biochemical Study. Indian J. Dent. Res. 2013;24:582–586. doi: 10.4103/0970-9290.123376. PubMed DOI

Fenol A., Swetha V.R., Krishnan S., Perayil J., Vyloppillil R., Bhaskar A., Shereef M., Balakrishnan B., Puzhankara L. Correlation of Salivary Neopterin and Plasma Fibrinogen Levels in Patients with Chronic Periodontitis and/or Type 2 Diabetes Mellitus. Pteridines. 2017;28:177–183. doi: 10.1515/pterid-2017-0007. DOI

Patil A., Ranganath V., Naresh Kumar C., Naik R., John A., Pharande S. Evaluation of Salivary Biomarkers of Periodontitis among Smokers and Nonsmokers: A Novel Study. J. Fam. Med. Prim. Care. 2020;9:1136. doi: 10.4103/jfmpc.jfmpc_937_19. PubMed DOI PMC

Pradeep A.R., Kumar M.S., Ramachandraprasad M.V., Shikha C. Gingival Crevicular Fluid Levels of Neopterin in Healthy Subjects and in Patients with Different Periodontal Diseases. J. Periodontol. 2007;78:1962–1967. doi: 10.1902/jop.2007.070096. PubMed DOI

Prasanna J.S., Sumadhura C., Karunakar P., Rekharani K., Himabindu G., Manasa A. Correlative Analysis of Plasma and Urine Neopterin Levels in the Pre- and Post-Menopausal Women with Periodontitis, Following Nonsurgical Periodontal Therapy. J. Indian Soc. Periodontol. 2017;21:276–284. doi: 10.4103/jisp.jisp_278_17. PubMed DOI PMC

Turgut Cankaya Z., Bodur A., Tacoy G., Erguder I., Aktuna D., Cengel A. The Effect of Periodontal Therapy on Neopterin and Vascular Cell Adhesion Molecule-1 Levels in Chronic Periodontitis Patients with and without Acute Myocardial Infarction: A Case-Control Study. J. Appl. Oral Sci. 2018;26:e20170199. doi: 10.1590/1678-7757-2017-0199. PubMed DOI PMC

Kaufman E., Lamster I.B. Analysis of Saliva for Periodontal Diagnosis: A Review. J. Clin. Periodontol. 2000;27:453–465. doi: 10.1034/j.1600-051x.2000.027007453.x. PubMed DOI